Latest Licensing News

Alicanto Minerals has acquired the Mt Henry Gold Project in Western Australia, boasting nearly 900,000 ounces of shallow, high-grade gold resources. The company is set to initiate a substantial $28 million equity raise to fund an extensive 50,000-metre drilling campaign aimed at rapidly expanding the resource base.

Comet Ridge Limited is set to acquire Santos’s 42.86% stake in the Mahalo Gas Project, consolidating full ownership and operator status. This move significantly increases the company’s gas reserves and positions it to better serve the east coast domestic gas market.

Proteomics International has secured a US patent for its PromarkerEso blood test, a pioneering diagnostic tool for early detection of esophageal adenocarcinoma, marking a critical step toward commercialisation in the world’s largest healthcare market.

PointsBet Holdings Limited has appointed Andrew Catterall as Group CEO effective February 2026, with founder Sam Swanell transitioning to an advisory role while remaining on the Board.

Sierra Nevada Gold (ASX – SNX) has won the rights to explore the expansive As Safra copper-gold project in Saudi Arabia, marking a strategic expansion into a high-potential mining district aligned with the Kingdom’s Vision 2030 ambitions.

Aureka Limited has raised $3.6 million through a share placement to fund a second diamond drill rig and accelerate exploration at its Victorian gold projects, reflecting strong investor confidence following recent high-grade discoveries.

AWAG has accelerated its growth trajectory by doubling its authorised representatives and increasing funds under management to $3.6 billion through strategic investments in Avalon Financial Services and SWR Chartered Accountants.

Emyria has secured its first Empax clinic in Victoria, marking a significant step in its multi-state expansion and validating its scalable, reimbursed national mental health platform.

Centrepoint Alliance forecasts a robust 13% increase in EBITDA for the first half of FY26, driven by strong adviser recruitment and platform scaling, cementing its position as the second-largest licensee in Australia.

Immutep Limited reports robust progress in its pivotal Phase III TACTI-004 trial for advanced non-small cell lung cancer, with over 120 clinical sites activated across 27 countries including the US. Patient enrolment has reached 38% of the target, keeping key milestones on track.

Diatreme Resources has submitted the Draft Environmental Impact Statement for its Northern Silica Project, marking a significant step toward regulatory approval and highlighting its potential to boost regional economies and support global solar energy growth.

Fortifai Limited has acquired an exclusive license to Nol8, a breakthrough real-time data processing technology developed by the Technion. This acquisition positions Fortifai to revolutionize data handling across gaming, AI, finance, and cybersecurity sectors.